Collegium Pharma (COLL): Emerging Leader in Opioid Pain Management - HC Wainwright

March 8, 2018 7:46 AM
H.C. Wainwright analyst, Ed Arce, reiterated his Buy rating on shares of Collegium Pharmaceutical (NASDAQ: COLL) and raised his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst EPS Change Analyst EPS View Analyst PT Change